Literature DB >> 27122882

Percutaneous Coronary Intervention for Left Main Coronary Artery Disease - A Single Hospital Experience without On-Site Cardiac Surgery.

Hsiao-Yang Cheng1, Kuang-Te Wang1, Wen-Hsiung Lin1, Jui-Peng Tsai2, Yung-Tzi Chen1.   

Abstract

BACKGROUND: To investigate the safety and outcome of percutaneous coronary intervention for left main coronary artery disease in hospital without on-site cardiac surgery.
METHODS: Between January 2007 and December 2010, all patients diagnosed with left main coronary artery disease and refused coronary artery bypass graft surgery in our hospital or a tertiary center, were enrolled. Data including clinical course, angiographic characteristics, and 1- and 3-years outcomes were recorded and analyzed.
RESULTS: Seventy patients (mean age 73.4 ± 10.2 years, 47 male, 23 females) were treated with a mean SYNTAX score of 34.8 ± 12.6 and EuroSCORE of 6.7 ± 3.3. Thirty-two (45.7%) patients had stable angina, 35 (50.0%) had unstable angina/non ST-elevation myocardial infarction, and 3 (4.3%) had ST-elevation Myocardial infarction. Forty-three (61.4%) patients received a single-stent, 26 (37.1%) received two-stents, and 1 (1.4%) received balloon angioplasty. No procedure-related mortalities were noted and no emergency coronary artery bypass graft surgery was required. In the 3-year follow-up period, 2 (2.9%) patients had non-fetal myocardial infarction, 11 (15.7%) had left main target lesion revascularization. The major adverse cardiac and cerebrovascular events rates were 24.3% at 1 year and 37.1% at 3-years. The all-cause mortality rate was 41.4% (29 patients), including 18 (25.7%) cases of septic shock, 7 (10.0%) of sudden cardiac death, 2 (2.8%) of hypovolemic shock due to upper gastrointestinal bleeding, 1 (1.4%) of terminal stage malignancy, and 1 (1.4%) of suffocation at 3 years.
CONCLUSIONS: Percutaneous coronary intervention for patients with left main coronary artery disease was found to be a safe and effective strategy in our hospital without on-site cardiac surgery. KEY WORDS: Incomplete revascularization; Left main coronary artery (LM); No cardiac surgery; Percutaneous coronary intervention (PCI).

Entities:  

Year:  2015        PMID: 27122882      PMCID: PMC4804922          DOI: 10.6515/acs20150119d

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  47 in total

1.  Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis.

Authors:  Enno Boudriot; Holger Thiele; Thomas Walther; Christoph Liebetrau; Peter Boeckstegers; Tilmann Pohl; Bruno Reichart; Harald Mudra; Florian Beier; Brigitte Gansera; Franz-Josef Neumann; Michael Gick; Thomas Zietak; Steffen Desch; Gerhard Schuler; Friedrich-Wilhelm Mohr
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

2.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

Authors:  Patrick W Serruys; Andrew T L Ong; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Clemens Disco; Bianca Backx; Paul G Hugenholtz; Brian G Firth; Felix Unger
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

3.  Long-term outcome of percutaneous coronary intervention for unprotected left main coronary artery disease.

Authors:  Xue-Ming Wu; Chung-Pin Liu; Wei-Cheng Lin; Hsien-Li Kao
Journal:  Int J Cardiol       Date:  2008-09-19       Impact factor: 4.164

4.  Outcomes of PCI at hospitals with or without on-site cardiac surgery.

Authors:  Thomas Aversano; Cynthia C Lemmon; Li Liu
Journal:  N Engl J Med       Date:  2012-03-25       Impact factor: 91.245

5.  Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study.

Authors:  Young-Hak Kim; Duk-Woo Park; Jung-Min Ahn; Sung-Cheol Yun; Hae Geun Song; Jong-Young Lee; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Yangsoo Jang; Myung-Ho Jeong; Hyo-Soo Kim; Seung-Ho Hur; Seung-Woon Rha; Do-Sun Lim; Sung-Ho Her; Ki Bae Seung; In-Whan Seong; Seung-Jung Park
Journal:  JACC Cardiovasc Interv       Date:  2012-07       Impact factor: 11.195

Review 6.  Current management of left main coronary artery disease.

Authors:  Jean Fajadet; Alaide Chieffo
Journal:  Eur Heart J       Date:  2012-01       Impact factor: 29.983

7.  Long-term prognosis in ethnic Chinese patients with unprotected left main coronary artery disease.

Authors:  Hui-Chun Huang; Hsien-Li Kao; Xue-Ming Wu; Sheoi-Shen Wang; Ron-Bin Hsu; Yi-Lwun Ho; Ming-Fong Chen
Journal:  Clin Res Cardiol       Date:  2010-03-14       Impact factor: 5.460

8.  Randomized trial of stents versus bypass surgery for left main coronary artery disease.

Authors:  Seung-Jung Park; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Jung-Min Ahn; Hae Geun Song; Jong-Young Lee; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Cheol-Hyun Chung; Jae-Won Lee; Do-Sun Lim; Seung-Woon Rha; Sang-Gon Lee; Hyeon-Cheol Gwon; Hyo-Soo Kim; In-Ho Chae; Yangsoo Jang; Myung-Ho Jeong; Seung-Jea Tahk; Ki Bae Seung
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

9.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

Authors:  A R Grüntzig; A Senning; W E Siegenthaler
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

10.  Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.

Authors:  Julinda Mehilli; Adnan Kastrati; Robert A Byrne; Olga Bruskina; Raisuke Iijima; Stefanie Schulz; Jürgen Pache; Melchior Seyfarth; Steffen Massberg; Karl-Ludwig Laugwitz; Josef Dirschinger; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2009-05-12       Impact factor: 24.094

View more
  1 in total

1.  Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Patients with Diabetic Nephropathy and Left Main Coronary Artery Disease.

Authors:  Hsin-Ru Li; Chiao-Po Hsu; Shih-Hsien Sung; Chun-Che Shih; Shing-Jong Lin; Wan-Leong Chan; Cheng-Hsueh Wu; Tse-Min Lu
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.